Shalu Narang
Pediatric Hematology-Oncology · Livingston, NJNPI 1134143878
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $19,764 of the $23,470 with a category attached, or 84.2%. 18 manufacturers reported payments, led by Global Blood Therapeutics, Inc. at 31.9% of the total. 2025 is the largest year on record at $10,466, more than ten times the $23 reported in 2019. Among pediatric hematology-oncology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 40 payments — averaging $586.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Global Blood Therapeutics, Inc.$7K
- Pfizer$7K
- Genentech USA, Inc.$5K
- Sanofi$4K
- Genetix Biotherapeutics Inc$128
- Novo Nordisk$125
- plus $377 from 12 others
Across 28 payments — averaging $1183.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$10K
- Pfizer$10K
- Genentech, Inc.$7K
- Boehringer Ingelheim$3K
- Global Blood Therapeutics, Inc.$3K
What the payments were for
- Consulting fees$19,76484%
- Speaking & faculty fees$1,7207%
- Travel & lodging$4912%
- Food & beverage$1,4966%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Global Blood Therapeutics, Inc. | 7 | $7,484 |
| Pfizer | 9 | $6,591 |
| Genentech USA, Inc. | 5 | $5,062 |
| Sanofi | 5 | $3,702 |
| Genetix Biotherapeutics Inc | 1 | $128 |
| Novo Nordisk | 1 | $125 |
| Sobi, Inc | 1 | $125 |
| Davol Inc. | 1 | $51 |
| 180 Medical, Inc. | 1 | $25 |
| Adaptive Biotechnologies Corporation | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| Novartis | 1 | $23 |
| Medunik USA Inc. | 1 | $22 |
| Day One Biopharmaceuticals | 1 | $18 |
| Merck | 1 | $18 |
| Agios Pharmaceuticals, Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Argon Medical Devices, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,470 in reported general payments places this provider in the 95th percentile of 54 pediatric hematology-oncology providers in New Jersey.
See all pediatric hematology-oncology providers in New Jersey →
Other pediatric hematology-oncology in Livingston
- Richard DrachtmanNew Brunswick$271K
- Niketa ShahNew Brunswick$29K
- Scott MoerdlerNew Brunswick$11K
- Burton AppelHackensack$5K
- Johannes ZakrzewskiHackensack$4K
- Bruce TerrinHackensack$3K
- Jill MenellPaterson$1K
- Peter ColeNew Brunswick$678
- Steven HalpernMorristown$625
- Marianna de BenedictisNewark$621
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.